Epidemiology of facial fractures: incidence, prevalence and years lived with disability estimates from the Global Burden of Disease 2017 study.


Journal

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention
ISSN: 1475-5785
Titre abrégé: Inj Prev
Pays: England
ID NLM: 9510056

Informations de publication

Date de publication:
10 2020
Historique:
received: 03 05 2019
revised: 07 08 2019
accepted: 12 08 2019
pubmed: 10 1 2020
medline: 31 8 2021
entrez: 10 1 2020
Statut: ppublish

Résumé

The Global Burden of Disease Study (GBD) has historically produced estimates of causes of injury such as falls but not the resulting types of injuries that occur. The objective of this study was to estimate the global incidence, prevalence and years lived with disability (YLDs) due to facial fractures and to estimate the leading injurious causes of facial fracture. We obtained results from GBD 2017. First, the study estimated the incidence from each injury cause (eg, falls), and then the proportion of each cause that would result in facial fracture being the most disabling injury. Incidence, prevalence and YLDs of facial fractures are then calculated across causes. Globally, in 2017, there were 7 538 663 (95% uncertainty interval 6 116 489 to 9 493 113) new cases, 1 819 732 (1 609 419 to 2 091 618) prevalent cases, and 117 402 (73 266 to 169 689) YLDs due to facial fractures. In terms of age-standardised incidence, prevalence and YLDs, the global rates were 98 (80 to 123) per 100 000, 23 (20 to 27) per 100 000, and 2 (1 to 2) per 100 000, respectively. Facial fractures were most concentrated in Central Europe. Falls were the predominant cause in most regions. Facial fractures are predominantly caused by falls and occur worldwide. Healthcare systems and public health agencies should investigate methods of all injury prevention. It is important for healthcare systems in every part of the world to ensure access to treatment resources.

Sections du résumé

BACKGROUND
The Global Burden of Disease Study (GBD) has historically produced estimates of causes of injury such as falls but not the resulting types of injuries that occur. The objective of this study was to estimate the global incidence, prevalence and years lived with disability (YLDs) due to facial fractures and to estimate the leading injurious causes of facial fracture.
METHODS
We obtained results from GBD 2017. First, the study estimated the incidence from each injury cause (eg, falls), and then the proportion of each cause that would result in facial fracture being the most disabling injury. Incidence, prevalence and YLDs of facial fractures are then calculated across causes.
RESULTS
Globally, in 2017, there were 7 538 663 (95% uncertainty interval 6 116 489 to 9 493 113) new cases, 1 819 732 (1 609 419 to 2 091 618) prevalent cases, and 117 402 (73 266 to 169 689) YLDs due to facial fractures. In terms of age-standardised incidence, prevalence and YLDs, the global rates were 98 (80 to 123) per 100 000, 23 (20 to 27) per 100 000, and 2 (1 to 2) per 100 000, respectively. Facial fractures were most concentrated in Central Europe. Falls were the predominant cause in most regions.
CONCLUSIONS
Facial fractures are predominantly caused by falls and occur worldwide. Healthcare systems and public health agencies should investigate methods of all injury prevention. It is important for healthcare systems in every part of the world to ensure access to treatment resources.

Identifiants

pubmed: 31915268
pii: injuryprev-2019-043297
doi: 10.1136/injuryprev-2019-043297
pmc: PMC7571355
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

i27-i35

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: SLJ works on a grant for influenza and respiratory syncytial disease that is funded by Sanofi Pasteur. This work does not relate to facial fracture burden.

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet Glob Health. 2015 Nov;3(11):e712-23
pubmed: 26475018
Ophthalmology. 2000 Oct;107(10):1875-9
pubmed: 11013191
J Craniofac Surg. 2015 Jan;26(1):108-12
pubmed: 25534050
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Br J Sports Med. 2017 Dec;51(24):1750-1758
pubmed: 27707740
Otolaryngol Head Neck Surg. 2014 Oct;151(4):591-8
pubmed: 25052515
JPRAS Open. 2018 Mar 27;16:84-92
pubmed: 32158816
J Oral Maxillofac Surg. 2011 Oct;69(10):2613-8
pubmed: 21683499
Clinicoecon Outcomes Res. 2017 Feb 07;9:107-113
pubmed: 28223831
J Craniofac Surg. 2017 May;28(3):785-788
pubmed: 28468166
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Lancet. 2018 Nov 10;392(10159):1995-2051
pubmed: 30496106
Inj Prev. 1996 Jun;2(2):140-9
pubmed: 9346079
Br J Oral Maxillofac Surg. 2014 Dec;52(10):901-6
pubmed: 25218316
Clin Geriatr Med. 2002 May;18(2):141-58
pubmed: 12180240
MMWR Morb Mortal Wkly Rep. 2016 Sep 23;65(37):993-998
pubmed: 27656914
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
J Trauma Acute Care Surg. 2014 Oct;77(4):630-4
pubmed: 25250606
J Am Geriatr Soc. 2008 Dec;56(12):2234-43
pubmed: 19093923
Indian J Plast Surg. 2010 Jan;43(1):42-8
pubmed: 20924449
J Urban Health. 2000 Mar;77(1):26-33
pubmed: 10741840
Dent Traumatol. 2013 Apr;29(2):115-20
pubmed: 22487364
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Pediatrics. 2001 May;107(5):1188-91
pubmed: 11331708
Pediatrics. 2003 Jun;111(6 Pt 1):e683-92
pubmed: 12777586
Dent Clin North Am. 2003 Jan;47(1):141-57, xi
pubmed: 12519011
Injury. 2001 Jun;32(5):353-6
pubmed: 11382418
Facial Plast Surg. 2005 Aug;21(3):214-20
pubmed: 16307402
Inj Prev. 2006 Dec;12(6):378-81
pubmed: 17170185
J Oral Maxillofac Surg. 2003 Jun;61(6):713-8
pubmed: 12796884
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Radiol Clin North Am. 2011 Jan;49(1):183-203
pubmed: 21111135
J Neurosurg. 1987 Apr;66(4):542-7
pubmed: 3559719
Oral Maxillofac Surg. 2012 Mar;16(1):3-17
pubmed: 21656125
J Trauma. 2007 Dec;63(6 Suppl):S54-67; discussion S81-6
pubmed: 18091213

Auteurs

Ratilal Lalloo (R)

School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia.

Lydia R Lucchesi (LR)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Catherine Bisignano (C)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Chris D Castle (CD)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Zachary V Dingels (ZV)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Jack T Fox (JT)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Erin B Hamilton (EB)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Zichen Liu (Z)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Nicholas L S Roberts (NLS)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Dillon O Sylte (DO)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.

Fares Alahdab (F)

Evidence Based Practice Center, Mayo Clinic Foundation for Medical Education and Research, Rochester, Minnesota, USA.

Vahid Alipour (V)

Health Management and Economics Research Center, Tehran, Iran.
Health Economics Department, Iran University of Medical Sciences, Tehran, Iran.

Ubai Alsharif (U)

Department of Oral and Maxillofacial Surgery, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.

Jalal Arabloo (J)

Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.

Mojtaba Bagherzadeh (M)

Chemistry Department, Sharif University of Technology, Tehran, Iran.

Maciej Banach (M)

Department of Hypertension, Medical University of Lodz, Lodz, Poland.
Polish Mothers' Memorial Hospital Research Institute, Lodz, Poland.

Ali Bijani (A)

Social Determinants of Health Research Center, Babol University of Medical Sciences, Babol, Iran.

Christopher Stephen Crowe (CS)

Division of Plastic Surgery, University of Washington, Seattle, Washington, USA.

Ahmad Daryani (A)

Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

Huyen Phuc Do (HP)

Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.

Linh Phuong Doan (LP)

Center of Excellence in Health Service Management, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.

Florian Fischer (F)

School of Public Health Medicine, Bielefeld University, Bielefeld, Germany.

Gebreamlak Gebremedhn Gebremeskel (GG)

Nursing Department, College of Health Science, Aksum University, Aksum, Ethiopia.
Nursing Department, Mekelle University, Mekelle, Ethiopia.

Juanita A Haagsma (JA)

Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.

Arvin Haj-Mirzaian (A)

Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran.
Obesity Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Arya Haj-Mirzaian (A)

Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran.
Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.

Samer Hamidi (S)

School of Health and Environmental Studies, Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates.

Chi Linh Hoang (CL)

Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.

Seyed Sina Naghibi Irvani (SSN)

Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Amir Kasaeian (A)

Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Yousef Saleh Khader (YS)

Department of Public Health and Community Medicine, Jordan University of Science and Technology, Ramtha, Jordan.

Rovshan Khalilov (R)

Department of Physiology, Baku State University, Baku, Azerbaijan.

Abdullah T Khoja (AT)

Department of Public Health, Imam Muhammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Department of Health Policy and Management, Johns Hopkins University, Baltimore, Maryland, USA.

Aliasghar A Kiadaliri (AA)

Clinical Epidemiology Unit, Lund University, Lund, Sweden.

Marek Majdan (M)

Department of Public Health, Trnava University, Trnava, Slovakia.

Navid Manaf (N)

Ophthalmology Department, Iran University of Medical Sciences, Tehran, Iran.
Ophthalmology Department, University of Manitoba, Winnipeg, Manitoba, Canada.

Ali Manafi (A)

Plastic Surgery Department, Iran University of Medical Sciences, Tehran, Iran.

Benjamin Ballard Massenburg (BB)

Division of Plastic Surgery, University of Washington, Seattle, Washington, USA.

Abdollah Mohammadian-Hafshejani (A)

Department of Epidemiology and Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Shane Douglas Morrison (SD)

Department of Surgery, University of Washington, Seattle, Washington, USA.

Trang Huyen Nguyen (TH)

Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.

Son Hoang Nguyen (SH)

Center of Excellence in Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh, Vietnam.

Cuong Tat Nguyen (CT)

Institute for Global Health Innovations, Duy Tan University, Hanoi, Vietnam.

Tinuke O Olagunju (TO)

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

Nikita Otstavnov (N)

Laboratory of Public Health Indicators Analysis and Health Digitalization, Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
Academic Department, Unium Ltd, Moscow, Russia.

Suzanne Polinder (S)

Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.

Navid Rabiee (N)

Chemistry Department, Sharif University of Technology, Tehran, Iran.

Mohammad Rabiee (M)

Biomedical Engineering Department, Amirkabir University of Technology, Tehran, Iran.

Kiana Ramezanzadeh (K)

Department of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Kavitha Ranganathan (K)

Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.

Aziz Rezapour (A)

Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.

Saeed Safari (S)

Emergency Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abdallah M Samy (AM)

Department of Entomology, Ain Shams University, Cairo, Egypt.

Lidia Sanchez Riera (L)

Rheumatology Department, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Institute of Bone and Joint Research, University of Sydney, Syndey, New South Wales, Australia.

Masood Ali Shaikh (MA)

Independent Consultant, Karachi, Pakistan.

Bach Xuan Tran (BX)

Department of Health Economics, Hanoi Medical University, Hanoi, Vietnam.

Parviz Vahedi (P)

Assistant Professor of Anatomical Sciences, Maragheh University of Medical Sciences, Maragheh, Iran.

Amir Vahedian-Azimi (A)

Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Zhi-Jiang Zhang (ZJ)

Department of Preventive Medicine, Wuhan University, Wuhan, China.

David M Pigott (DM)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, Washington, USA.

Simon I Hay (SI)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, Washington, USA.

Ali H Mokdad (AH)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, Washington, USA.

Spencer L James (SL)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA spencj@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH